Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1911010, Zurich, Switzerland

Nextech Invest Ltd. reported $536,819,845 across 11 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-14. Its ten largest share positions make up 98.05% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-023793

Period
2023-12-31
Reported value
$537M
Holdings
11
Top 10 weight
98.05%
New
3
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CARGO THERAPEUTICS INC COMnew+2,642,502$61.2M
ARVNadded+1,408,394$58M
AMBRX BIOPHARMA INCnew+3,129,300$44.6M
RVMDadded+1,457,211$41.8M
Mersana Therapeutics Incnew+5,978,327$13.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EQRX INCexited-13,104,424-$29.1M
KINNATE BIOPHARMA INCexited-2,329,480-$3.26M
PMVPexited-421,284-$2.59M
KRONOS BIO INCexited-1,451,537-$1.89M
THESEUS PHARMACEUTICALS INCexited-611,310-$1.64M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0001104659-24-023793, largest first. % of portfolio is the value over $536,819,845, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,839,529 shares; 2023Q2: 4,839,529 shares; 2023Q3: 4,839,529 shares; 2023Q4: 6,296,740 shares 6,296,740$181M33.64%+1,457,211Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 287,251 shares; 2023Q2: 287,251 shares; 2023Q3: 287,251 shares; 2023Q4: 1,695,645 shares 1,695,645$69.8M13%+1,408,394Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 2,642,502 shares 2,642,502$61.2M11.4%new
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 5,533,980 shares; 2023Q4: 5,533,980 shares 5,533,980$54.8M10.21%0Timeline
AMBRX BIOPHARMA INCAMBRX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 3,129,300 shares 3,129,300$44.6M8.3%new
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 4,285,714 shares; 2023Q3: 4,285,714 shares; 2023Q4: 4,285,714 shares 4,285,714$39.4M7.34%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,518,582 shares; 2023Q2: 2,518,582 shares; 2023Q3: 2,518,582 shares; 2023Q4: 2,518,582 shares 2,518,582$34.9M6.5%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 625,485 shares; 2023Q2: 948,659 shares; 2023Q3: 1,196,409 shares; 2023Q4: 1,346,409 shares 1,346,409$14.8M2.76%+150,000Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 5,978,327 shares 5,978,327$13.9M2.58%new
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,221,145 shares; 2023Q2: 1,221,145 shares; 2023Q3: 1,221,145 shares; 2023Q4: 1,221,145 shares 1,221,145$12.4M2.32%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,910,029 shares; 2023Q2: 1,910,029 shares; 2023Q3: 1,910,029 shares; 2023Q4: 1,910,029 shares 1,910,029$10.5M1.95%0Timeline

Sold out in Q4 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
EQRX INCEQRX INC13,104,424$29.1Mshares
KINNATE BIOPHARMA INCKINNATE BIOPHARMA INC2,329,480$3.26Mshares
PMVPPMV PHARMACEUTICALS INC421,284$2.59Mshares
KRONOS BIO INCKRONOS BIO INC1,451,537$1.89Mshares
THESEUS PHARMACEUTICALS INCTHESEUS PHARMACEUTICALS INC611,310$1.64Mshares
CCCCC4 THERAPEUTICS INC375,857$699Kshares

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-023793 base2024-02-14acceptance time not in the bulk data set